PURPOSE The study of plasma cell-free DNA integrity (cfDI) has shown potential for providing useful information in neoplastic patients. The aim of this study is to estimate the accuracy of an electrophoresis-based method for cfDI evaluation in the assessment of pathologic complete response (pCR) in patients with breast cancer (BC) undergoing...
-
2022 (v1)PublicationUploaded on: April 14, 2023
-
2019 (v1)Publication
In the original publication of the article, the funding information was incorrectly published. The corrected funding statement is given in this correction article.
Uploaded on: April 14, 2023 -
2019 (v1)Publication
Purpose: Breast cancer (BC) is a heterogeneous disorder, with variable response to systemic chemotherapy. Likewise, BC shows highly complex immune activation patterns, only in part reflecting classical histopathological subtyping. Schlafen-11 (SLFN11) is a nuclear protein we independently described as causal factor of sensitivity to DNA...
Uploaded on: April 14, 2023